High doses of biotin in chronic progressive multiple sclerosis: A pilot study

2015223 citationsJournal Articlehybrid Open Access

Authors

Frédéric Sedel · Assistance Publique – Hôpitaux de Paris

Caroline Papeix · Pitié-Salpêtrière Hospital

Agnès Bellanger · Sorbonne Université

Valérie Touitou · Sorbonne Université

Christine Lebrun‐Frénay · Hôpital Pasteur

Damien Galanaud · Sorbonne Université

Olivier Gout ·

Abstract

These preliminary data suggest that high doses of biotin might have an impact on disability and progression in progressive MS. Two double-blind placebo-controlled trials are on going.

Topics & Keywords

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Multiple Sclerosis and Related Disorders

Volume 4, Issue 2, pp. 159-169

DOI: 10.1016/j.msard.2015.01.005

Field-Weighted Citation Impact: 16.55